NuCana (NCNA) Non-Current Assets (2016 - 2025)

NuCana's (NCNA) quarterly Non-Current Assets came in at $4.0 million in Q4 2025, up 22.8% year-on-year from $3.2 million in Q4 2024, and up 18.32% quarter-over-quarter from $3.3 million in Q3 2025.

NuCana (NCNA) Non-Current Assets (2016 - 2025) Analysis & Trends

NuCana has disclosed Non-Current Assets across 10 years of filings, most recently posting $4.0 million for Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $4.0 million, up 22.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.0 million (up 22.8% YoY), and the FY2025 annual result was $3.9 million, up 22.22% from the prior year.
  • Non-Current Assets came in at $4.0 million for Q4 2025 at NuCana, up from $3.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $11.7 million in Q3 2021 to a low of $3.1 million in Q1 2025.
  • The 5-year median for Non-Current Assets is $4.0 million (2023), against an average of $5.3 million.
  • Across the five-year window, Non-Current Assets soared 50.99% in 2021 and slumped 50.5% in 2022, its largest moves.
  • NuCana's Non-Current Assets stood at $7.9 million in 2021, then plunged by 50.5% to $3.9 million in 2022, then retreated by 11.39% to $3.5 million in 2023, then decreased by 7.07% to $3.2 million in 2024, then advanced by 22.8% to $4.0 million in 2025.
  • The last three Non-Current Assets figures came in at $4.0 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 62,953.78
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4.56 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 30.30 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.26 Bn 94.26 Bn - 39.71 Mn
10 NuCana 29.13 Bn 29.13 Bn - 3.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.95 Mn
Sep 30, 2025 3.34 Mn
Jun 30, 2025 3.32 Mn
Mar 31, 2025 3.13 Mn
Dec 31, 2024 3.22 Mn
Sep 30, 2024 3.45 Mn
Jun 30, 2024 3.44 Mn
Mar 31, 2024 3.49 Mn
Dec 31, 2023 3.47 Mn
Sep 30, 2023 4.21 Mn
Jun 30, 2023 4.21 Mn
Mar 31, 2023 4.10 Mn
Dec 31, 2022 3.91 Mn
Sep 30, 2022 7.34 Mn
Jun 30, 2022 7.26 Mn
Mar 31, 2022 7.86 Mn
Dec 31, 2021 7.90 Mn
Sep 30, 2021 11.69 Mn
Jun 30, 2021 8.23 Mn
Mar 31, 2021 8.14 Mn